🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Why Heart Disease Research Still Favors Men | TIME ⁦Erin D. Michos, M.D.⁩ ⁦Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦⁩ ⁦Nadeen N. Faza, M.D.⁩ ⁦Karol Watson⁩ ⁦Garima Sharma M.D⁩ time.com/6962474/heart-…

⁦Khurram Nasir⁩ ⁦Salim Virani⁩ ⁦Kershaw Patel⁩ ⁦Usman A. Akbar, MD⁩ link.springer.com/article/10.100…

“Humans” beyond borders!

Racial and ethnic disparities were observed for almost all leading causes of injury and disease that were associated with recent increases in youth mortality. ja.ma/3XjQNHl

🏭 Higher levels of long-term Particulate matter 2.5 (#AirQuality) exposure ⏯️ 🔺️🔺️🔺️#CVD ❤️, #Cancer & comorbid cancer+CVD #cardioonc mortality 🥀 Pronounced detrimental effect in vulnerable & minority population #AirPollution matters 🌍 #planetaryhealth is not

The long awaited return of the Houston Methodist Valve Journal Club. Just 26 friends and colleagues having a great dinner and discussing TAVR vs SAVR outcomes (non-inferiority) and durability. Thank you ⁦Isadora Mathias, MD⁩ and ⁦Safi U. Khan, MD, MS⁩ for a great discussion. ⁦#iEcho

1. Do patients with chronic kidney disease get similar quality of care as those without following admission with a heart attack in England and Wales? See here➡️ ahajournals.org/doi/epub/10.11… Our study led by Nick Weight studies >350,000 pts from uk heart attack registry to assess this

Our editorial — Enhancing Access to Transcatheter Tricuspid Interventions Amid Disparities | JACC: Advances jacc.org/doi/10.1016/j.… Sachin Goel WilliamZoghbi Houston Methodist CV Stephen Little, MD

The Exposome & CV Health—new #DeBakeyCVJournal issue—published today! Special thanks to guest editors Sadeer Al-Kindi, MD & Khurram Nasir & our amazing authors Bassel Daher Safi U. Khan, MD, MS @hjryooali Anita Deswal BunieN et al journal.houstonmethodist.org M Quinones MD, MACC Houston Methodist CV Nadeen N. Faza, M.D.

Cheers to Rody Bou Chaaya, Taha Hatab, Sahar Samimi, MD et al. & the leadership —Neal Kleiman, Alpesh Shah M.D., Sachin Goel, WilliamZoghbi—for creating the HM Young ACS-PCI Registry. A valuable resource for advancing care in young ACS patients! 📄: sciencedirect.com/science/articl…"

Elderly patient with mod/sev AS (AVA 0.9-1), severe LM bifurcation, RCA CTO, severe PAD with EVAR, iliac stents and femo-popliteal bypass ==> Impella assisted LM PCI using Mini-crush, no need for BAV Houston Methodist CV Houston Methodist Cardiovascular Fellowships Safi U. Khan, MD, MS SCAI #ACCFIT #Cardiotwitter #Cardiology

📢 New Study in JACC Journals TAVR in high-risk patients with native AR: Dedicated devices (JenaValve/J-Valve) deliver: ✔️ Lower 30-day mortality ✔️ Higher device success ✔️ Fewer complications (residual AR, valve migration, PPI) Read more: sciencedirect.com/science/articl…

Neighborhood-level SDoH’s—socioeconomic status, racial segregation & environmental factors—significantly impact CVD: “Zip Code Health Disparities: Mapping Cardiovascular Inequities at the Neighborhood Level” by Safi U. Khan, MD, MS #DeBakeyCVJournal doi.org/10.14797/mdcvj… Earn free CME

Heart Disease in South Asians, Premature Heart Disease conversation with Rahul Menon of ⁦Indian Diaspora⁩ youtube.com/watch?v=nNhvzW…

Beta-Blockers After PCI for Stable Coronary Artery Disease and Preserv... sciencedirect.com/science/articl… Houston Methodist CV

I am glad to share our observational study, which adds to the growing evidence on beta-blockers post-PCI in the upcoming issue of JACC Journals for stable CAD with preserved LVEF. Thank you, Dr. Safi Khan, for providing continuous mentorship. 📊 Key Findings: •Higher all-cause

Congrats Sahar Samimi, MD Houston Methodist Safi U. Khan, MD, MS Chloe Kharsa Rody Bou Chaaya Fatima Qamar, MD, MPH. Joe Aoun Syed Zaid, MD Nadeen N. Faza, M.D. Stephen Little, MD WilliamZoghbi MATKINS Michael Reardon NKleiman Khurram Nasir Dipan J. Shah, MD Mouaz Al-Mallah, M.D MSc Carlos El-Tallawi, MD “HeartToProve” Mohammed Chamsi Pasha, FACC, FASE Alan Lumsden, MD, CV Chairman/Director

Excited to share my latest publication in @AJConline! Thank you, Safi U. Khan, MD, MS, for the mentorship and opportunity. We analyzed 16,209 young adults (18–50) undergoing PCI for myocardial infarction (MI) between 2011–2023 using real-world TriNetX data.

Our JACC Journals editorial discusses individual variability in cardiometabolic response to Tirzepatide (jacc.org/doi/10.1016/j.…) On the individual-level meta by Aminorroaya et al.: jacc.org/doi/10.1016/j.… Khurram Nasir, Ambarish Houston Methodist

Thank you, Safi U. Khan, MD, MS, ambarish & Khurram Nasir, for the thoughtful discussion of our JACC Journals paper on the efficacy of tirzepatide for cardiometabolic outcomes and its heterogeneous treatment effects across individuals. Rohan Khera CarDS Lab Yale Cardiology Yale Internal Medicine